314 related articles for article (PubMed ID: 29948178)
21. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
Nonobe NI; Kachi S; Kondo M; Takai Y; Takemoto K; Nakayama A; Hayakawa M; Terasaki H
Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
[TBL] [Abstract][Full Text] [Related]
22. Refractive error outcomes after intravitreal ranibizumab for retinopathy of prematurity.
Meng Q; Cheng Y; Wu X; Zhao D; Zhao M; Liang J
Clin Exp Optom; 2020 Jul; 103(4):495-500. PubMed ID: 31802528
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab.
Zhou Y; Jiang Y; Bai Y; Wen J; Chen L
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):31-6. PubMed ID: 25851862
[TBL] [Abstract][Full Text] [Related]
24. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.
Ling KP; Liao PJ; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity.
Cheng Y; Zhu X; Linghu D; Liang J
Acta Ophthalmol; 2020 Dec; 98(8):e1004-e1008. PubMed ID: 32385940
[TBL] [Abstract][Full Text] [Related]
26. The severity and associated comorbidities of retinopathy of prematurity among micro-premature infants with birth weights less than 750 grams.
Beck K; Young R; Read S; Harper H; Desireddi J; Harper CA
J Neonatal Perinatal Med; 2019; 12(1):41-45. PubMed ID: 30400108
[TBL] [Abstract][Full Text] [Related]
27. Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study.
Patel NA; Acaba-Berrocal LA; Hoyek S; Fan KC; Martinez-Castellanos MA; Baumal CR; Harper CA; Berrocal AM;
Ophthalmology; 2023 Apr; 130(4):373-378. PubMed ID: 36396121
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Nov; 116(11):2165-9. PubMed ID: 19700197
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children.
Kabataş EU; Kurtul BE; Altıaylık Özer P; Kabataş N
Curr Eye Res; 2017 Jul; 42(7):1054-1058. PubMed ID: 28128986
[TBL] [Abstract][Full Text] [Related]
30. Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
Zhou M; Wang J; Wang W; Huang W; Ding X; Zhang X
PLoS One; 2016; 11(1):e0146993. PubMed ID: 26785251
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of 'sawtooth shunt' following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity.
Padhi TR; Das T; Kaur P; Sutar S; Khalsa A; Modi R; Ali H; Pradhan L; Jalali S
Int Ophthalmol; 2020 Apr; 40(4):1007-1015. PubMed ID: 31925658
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.
Motohashi R; Noma H; Yasuda K; Kotake O; Goto H; Shimura M
Ophthalmic Res; 2017; 58(4):209-216. PubMed ID: 28796997
[TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial.
Wu Z; Zhao J; Lam W; Yang M; Chen L; Huang X; Wei M; Yang H; Lv F; Zhang F; Zeng J; Zhang GM
Br J Ophthalmol; 2022 Jul; 106(7):975-979. PubMed ID: 33637618
[TBL] [Abstract][Full Text] [Related]
34. Treatment for stage 4A retinopathy of prematurity: laser and/or ranibizumab.
Sukgen EA; Koçluk Y
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):263-269. PubMed ID: 27495302
[TBL] [Abstract][Full Text] [Related]
35. Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity.
Parchand SM; Agrawal D; Gangwe A; Saraogi T; Agrawal D
Indian J Ophthalmol; 2021 Aug; 69(8):2164-2170. PubMed ID: 34304202
[TBL] [Abstract][Full Text] [Related]
36. [The clinical study on intravitreous injection of ranibizumab for aggressive posterior retinopathy of prematurity].
Tian R; Zhang G; Tang S; Guo J; Tan W
Zhonghua Yan Ke Za Zhi; 2015 Nov; 51(11):822-5. PubMed ID: 26850583
[TBL] [Abstract][Full Text] [Related]
37. The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration.
Rezar-Dreindl S; Sacu S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Weigert G; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4144-50. PubMed ID: 27537264
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.
Kong L; Demny AB; Sajjad A; Bhatt AR; Devaraj S
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1649-54. PubMed ID: 27054517
[TBL] [Abstract][Full Text] [Related]
39. Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.
Stahl A; Krohne TU; Eter N; Oberacher-Velten I; Guthoff R; Meltendorf S; Ehrt O; Aisenbrey S; Roider J; Gerding H; Jandeck C; Smith LEH; Walz JM;
JAMA Pediatr; 2018 Mar; 172(3):278-286. PubMed ID: 29309486
[TBL] [Abstract][Full Text] [Related]
40. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.
Roh MI; Kim HS; Song JH; Lim JB; Kwon OW
Ophthalmology; 2009 Jan; 116(1):80-6. PubMed ID: 19118699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
